Episode Details

New studies question psychedelics and cannabis for depression treatment, finding no solid evidence they work better than standard antidepressants. Researchers warn of potential risks and lack of long-term benefits. Despite growing prescriptions in Australia, experts call for more high-quality studies before these substances become first-line treatments.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/85854061ab411809